Frias JP, Gonzalez-Galvez G, Johnsson E, Maaske J, et al. Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial. Diabetes Obes Metab 2020 Feb 12. doi: 10.1111/dom.13997.
PMID: 32052516